2005, Leads and Pharmaceutical research

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2005

Leads

Pharmaceutical research

Paving the way for anti-Abeta active immunotherapy

European Pharmaceutical Review

SEPTEMBER 22, 2023

Targeting toxic species of Abeta, such as multimers (with aducanumab and lecanemab) or pyroglutamate Abeta3-42 (with donanemab), induced significant removal of Abeta plaque load in the brains of Alzheimer’s patients, leading to the delay in cognitive decline. Treatment with the mAbs delayed cognitive decline by 2.6 months for lecanemab and 5.5

Food and Drug Administration

Food and Drug Administration Safety Patients Leads

Healthcare Industry Innovators and Workplace Equality Advocates Announced as 2022 Award Recipients by the Healthcare Businesswomen’s Association

Pharma Marketing Network

JANUARY 26, 2022

Throughout her decades-long career, Seidenberg has transformed the lives of millions of patients by championing pharmaceutical research and development leading to the introduction of innovative life-saving products that treat diseases like AIDS, arthritis, asthma, cancer, and others.

Healthcare

Healthcare Healthcare Networking Recruitment

Pharma Rep Focus

Paving the way for anti-Abeta active immunotherapy

Healthcare Industry Innovators and Workplace Equality Advocates Announced as 2022 Award Recipients by the Healthcare Businesswomen’s Association

Stay Connected